Association of immunoescape mechanisms with Epstein‐Barr virus infection in nasopharyngeal carcinoma
Open Access
- 27 March 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (11), 2401-2410
- https://doi.org/10.1002/ijc.22334
Abstract
We have investigated the association of immunoescape mechanisms in nasopharyngeal carcinoma (NPC) lesions with Epstein-Barr virus (EBV) infection and clinical course of the disease. Tumor biopsy specimens obtained from 36 Japanese NPC patients were examined for antigen processing machinery component and HLA class I antigen expression, CD8+ T cell infiltration, and Fas, Fas ligand (FasL) and IL-10 expression using immunohistochemical staining. The results were correlated with the histopathological characteristics of the lesions, the clinical course of the disease and EBV infection. LMP2, TAP1, tapasin and HLA class I antigens were downregulated in more than 65% of the lesions tested, while FasL, Fas and IL-10 were expressed in at least 60% of the lesions. Statistical analysis showed that (i) HLA class I antigen expression was significantly correlated with LMP2 and tapasin expression (r = 0.39 and 0.45, respectively); (ii) CD8+ T cell infiltration into tumor lesions was significantly correlated with HLA class I antigen, LMP2 and Fas expression (r = 0.34, 0.49 and 0.44, respectively); (iii) LMP2 and FasL expression was significantly correlated with IL-10 expression (r = 0.49 and 0.52, respectively); (iv) IL-10 expression was significantly associated with EBERs and EBV oncoprotein LMP1 expression (p = 0.00078 and 0.015, respectively) and (v) FasL overexpression was significantly associated with reduced patients' survival (p = 0.033). Multivariate analysis identified FasL overexpression as an independent unfavorable prognostic marker. These results suggest that NPC cells may utilize multiple immunoescape mechanisms, including dysfunction of HLA class I antigens and Fas/FasL apoptosis pathways. Furthermore, FasL expression appears to be associated with IL-10 upregulation in EBV positive NPC cells.Keywords
This publication has 38 references indexed in Scilit:
- Development and characterization of human constitutive proteasome and immunoproteasome subunit‐specific monoclonal antibodiesTissue Antigens, 2005
- Prognostic implications of Fas-ligand expression in nasopharyngeal carcinomaHead & Neck, 2004
- IL‐12 receptor‐mediated upregulation of FasL in human ovarian carcinoma cellsInternational Journal of Cancer, 2004
- The role of Fas ligand and transforming growth factor β in tumor progressionCancer, 2004
- Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinomaThe Journal of Pathology, 2003
- Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinomaCancer, 2003
- Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinomaCancer, 2002
- Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumorsCancer, 2002
- β2-μ-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with β2-μ-associated HLA class I heavy chain levels and HLA phenotypeTissue Antigens, 1999
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958